Physician

Andrew B. Shaffer

According to 2025 Medicare claims, Andrew Shaffer (NPI: 1104359561) practices rheumatology in the Bend, OR market, with the plurality of this provider's patient population coming from Deschutes, OR. This provider's primary affiliated billing organization is ST. CHARLES HEALTH SYSTEM, INC. (NPI: 1023331303; TIN: 272006180) and primary practice location at 97701-6337. Shaffer is affiliated with the Pearl Primary Care Network, LLC (ACO ID: D0242), participating under the REACH model.

Shaffer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 482 traditional Medicare patients, billed 94,897 HCPCS/CPT codes, and received $919,697 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,317 prescription claims across 263 beneficiaries totaling $1,051,915 in drug costs, led by Humira(Cf) Pen (Adalimumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,165 to $1,051,915. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$460K$920K2022 Medicare payment: $64,168 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $602,361 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $919,697 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022895,473$64,168
202339358,171$602,361
202448294,897$919,697

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$526K$1.1M2017 Drug cost: $1,165 (USD; Tot_Drug_Cst)2018 Drug cost: $1,924 (USD; Tot_Drug_Cst)2019 Drug cost: $2,396 (USD; Tot_Drug_Cst)2020 Drug cost: $782 (USD; Tot_Drug_Cst)2021 Drug cost: $6,115 (USD; Tot_Drug_Cst)2022 Drug cost: $99,015 (USD; Tot_Drug_Cst)2023 Drug cost: $489,147 (USD; Tot_Drug_Cst)2024 Drug cost: $1,051,915 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171330$1,165
20182047$1,924
2019N/R25$2,396
2020N/R21$782
20212066$6,115
202267194$99,015
2023186911$489,147
20242631,317$1,051,915

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more153314$87
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less115180$47
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's136196$13
96372Injection of drug or substance under skin or into muscle105326$11
J3489Injection, zoledronic acid, 1 mg90450$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab30924$217,419
KevzaraSarilumab19784$124,747
Actemra ActpenTocilizumab15476$64,194
Hydroxychloroquine SulfateHydroxychloroquine Sulfate16612,880$10,022
LeflunomideLeflunomide743,852$6,423

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Andrew B. Shaffer?

Tedicare shows public-source Medicare data for Andrew B. Shaffer (NPI 1104359561), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew B. Shaffer have ACO affiliation data?

Andrew B. Shaffer is shown with ACO affiliation data for Pearl Primary Care Network, LLC (REACH, ACO ID D0242).

What billing organization is linked to Andrew B. Shaffer?

Andrew B. Shaffer is linked to ST. CHARLES HEALTH SYSTEM, INC. (billing NPI 1023331303) in the available physician profile data.

Does Andrew B. Shaffer have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.